SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
EVGN

Evogene Ltd. (NASDAQ:EVGN)

IL · Delayed Price · Currency is USD
Also listed: EVGN.TAHealthcare · Biotechnology
$0.32+$0.00 (+1.02%)
 
Market cap
$2.72M
Insider Score
Health Score
Analyst consensus
Listed since
Oct 15, 2010
Market Cap$2.72M-72.5%
Revenue (ttm)$1.14M-78.4%
Net Income-$15.80M-474.8%
EPS-$1.52-205.7%
Shares Out8.62M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume62,775
Open$0.33
Previous Close$0.31
Day's Range$0.30 - $0.33
52-Week Range$0.25 - $1.26
Beta0.68
AnalystsBuy
Price Target$2.15(+579.95%)
Earnings DateMar 4, 2027
+2.24% (1D)
No price history available.

About EVGN

Evogene Ltd. is a computational biology firm specializing in the identification and advancement of products across human health and agricultural sectors. Its proprietary Computational Predictive Biology (CPB) platform leverages deep biological insights, big data, and artificial intelligence to precisely uncover and guide the creation of life science solutions, including novel microbes, small molecules, and genetic components. The company operates through distinct divisions: Agriculture, Human Health, and Industrial Applications. The Agriculture division concentrates on improving crop performance through the development of advanced seed traits, agricultural chemicals, and biological products for crops like corn, soybean, wheat, rice, and cotton. The Human Health division focuses on pioneering microbiome-based treatments for conditions such as immuno-oncology, gastrointestinal ailments, and antibiotic-resistant infections, and also offers medical cannabis products. The Industrial Applications segment is dedicated to developing improved castor bean varieties for various industrial feedstock requirements. Evogene has a global footprint, conducting business in the United States, Israel, Brazil, and other international markets. It maintains significant partnerships, including agricultural collaborations with BASF SE, Corteva, and Bayer, and a medical cannabis development agreement with Cannbit Ltd. through its subsidiary, Canonic Ltd. Established in 1999, Evogene Ltd. is headquartered in Rehovot, Israel.

Address
13 Gad Feinstein Street, Rehovot, HM, 7638517, IL
Market Cap
3 million
Employees
52
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$692.78K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Weak
From EVGN’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
+1.02%
5 Days
-16.79%
1 Month
-15.88%
6 Months
-54.83%
1 Year
-72.50%

$EVGN stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in EVGN holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by EVGN's directors and management

Net Shares Purchased by Insiders−2M−1M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

EVGN Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New EVGN patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to EVGN from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from EVGN’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
26.67
Analyst Ratings
32% of score
60
News & Sentiment
20% of score
62

News check: Q3 2026 earnings with progress in development programs and AgPlenus fungicide advances support moderately positive sentiment, tempered by valuation concerns.

Recent Insider Activity

Buys
3
Sells
0
Buy Value
$692.78K
Distinct Buyers
2

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.